(Q28258206)

1

0 references

Chang-Yao Hsieh

3

0 references

Chien-Nan Lee

4

0 references

Yi-Ning Su

5

0 references

Yu-Hao Hu

6

0 references

Wen-Fang Cheng

Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma

7

0 references

language of work or name

English

0 references

publication date

10 December 2009

0 references

published in

Biochemical Journal

0 references

volume

424

0 references

issue

3

0 references

page(s)

449-58

0 references

cites work

1 reference

Mesothelin: a new target for immunotherapy

20 April 2017

1 reference

High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma

20 April 2017

1 reference

A standard curve based method for relative real time PCR data processing

20 April 2017

1 reference

Plasma-membrane-associated sialidase (NEU3) differentially regulates integrin-mediated cell proliferation through laminin- and fibronectin-derived signalling

20 April 2017

1 reference

Mesothelin promotes anchorage-independent growth and prevents anoikis via extracellular signal-regulated kinase signaling pathway in human breast cancer cells

20 April 2017

1 reference

Gene expression patterns in ovarian carcinomas

20 April 2017

1 reference

Estimates of the worldwide incidence of eighteen major cancers in 1985.

20 April 2017

1 reference

https://api.crossref.org/works/10.1042%2FBJ20082196

Time trends in ovarian cancer mortality in Europe (1955-1993): effect of age, birth cohort and period of death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20082196

Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20082196

Generation and characterization of an ascitogenic mesothelin-expressing tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20082196

Paclitaxel-induced cell death: where the cell cycle and apoptosis come together

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20082196

Modulation of cisplatin sensitivity by taxol in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20082196

Molecular signals in anti-apoptotic survival pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20082196

The essential role for c-Ski in mediating TGF-beta1-induced bi-directional effects on skin fibroblast proliferation through a feedback loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20082196

Erythropoietin regulates vascular smooth muscle cell apoptosis by a phosphatidylinositol 3 kinase-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20082196

Morphine induces apoptosis of human endothelial cells through nitric oxide and reactive oxygen species pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20082196

Serial killers: ordering caspase activation events in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20082196

Mesothelin variant 1 is released from tumor cells as a diagnostic marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20082196

Forced expression of deltaN-TCF-1B in colon cancer derived cell lines is accompanied by the induction of CEACAM5/6 and mesothelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20082196

Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20082196

The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20082196

Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20082196

Farnesyltransferase inhibitors interact synergistically with the Chk1 inhibitor UCN-01 to induce apoptosis in human leukemia cells through interruption of both Akt and MEK/ERK pathways and activation of SEK1/JNK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20082196

Clinical and molecular differences between clear cell and papillary serous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20082196

P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20082196

Mesothelin is not required for normal mouse development or reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20082196

Mesothelin-mediated targeting of adenoviral vectors for ovarian cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20082196

Anti-tumor activity of K1-LysPE38QQR, an immunotoxin targeting mesothelin, a cell-surface antigen overexpressed in ovarian cancer and malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20082196

Soluble Mesothelin Related Protein in Mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20082196

A target for Pl(3) kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20082196

Insulin-like Growth Factor 1 Inhibits Apoptosis Using the Phosphatidylinositol 3′-Kinase and Mitogen-activated Protein Kinase Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20082196